Literature DB >> 8652364

Distribution of viral RNA in the spinal cord of DBA/2 mice developing biphasic paralysis following infection with the D variant of encephalomyocarditis virus (EMC-D).

M Takeda1, R Miura, K Shiota, K Hirasawa, M J Lee, S I Itagaki, K Doi.   

Abstract

DBA/2 mice infected with the D variant of encephalomyocarditis virus (EMC-D) (10(1) PFU/head) developed biphasic hind limb paralysis. As a first step in clarifying its pathogenesis, we examined the distribution of viral RNA in the spinal cord using in situ hybridization. At 3 days post inoculation (DPI), in the spinal cord of mice showing slight paralysis, viral RNA was observed in capillary endothelial cells and a few adjacent glia cells in the funiculus lateralis from thoracic to lumbar enlargement. At 7 DPI, in the spinal cord of mice showing apparent paralysis, viral RNA was observed in a larger number of glia cells in the demyelinated lesion associated with infiltration of macrophages in the funiculus lateralis and in a small number of degenerated neurons in the cornu ventrale. In the funiculus lateralis, viral RNA could not be observed after 28 DPI. On the other hand, viral RNA was observed in degenerated neurons in the cornu ventrale of mice showing the second phase paralysis at 42 DPI. Many CD4+T cells infiltrated around these degenerated neurons. These results suggest that: (1) the viral entry zone was the capillary endothelial cells in the funiculus lateralis; (2) first phase paralysis was due to demyelination caused by EMC-D and associated with macrophage infiltration; (3) second phase paralysis was due to degeneration of motor neurons bearing viral RNA associated with infiltration by CD4+T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8652364      PMCID: PMC1997210     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  21 in total

1.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus.

Authors:  Y S Bae; H M Eun; J W Yoon
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

3.  Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody.

Authors:  M Rodriguez; S Sriram
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  Long-term complications of virus-induced diabetes mellitus in mice.

Authors:  J W Yoon; M M Rodrigues; C Currier; A L Notkins
Journal:  Nature       Date:  1982-04-08       Impact factor: 49.962

5.  Biphasic disease of central nervous system induced in DBA/2 mice by the D variant of encephalomyocarditis virus (EMC-D).

Authors:  M Takeda; S Itagaki; K Doi
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

6.  A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis.

Authors:  M Juhler; R G Blasberg; J D Fenstermacher; C S Patlak; O B Paulson
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

7.  Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus.

Authors:  M D Lindsley; M Rodriguez
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

8.  Rapid development of renal lesions in diabetic DBA mice infected with the D-variant of encephalomyocarditis virus (EMC-D).

Authors:  K Doi; H Matsuzaki; T Tsuda; T Onodera
Journal:  Br J Exp Pathol       Date:  1989-06

9.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization.

Authors:  M E Cronin; L A Love; F W Miller; P R McClintock; P H Plotz
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  5 in total

1.  Age-related changes in susceptibility of rat brain slice cultures including hippocampus to encephalomyocarditis virus.

Authors:  W Su; A Ueno-Yamanouchi; K Uetsuka; H Nakayama; K Doi
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  K Hirasawa; H S Jun; K Maeda; Y Kawaguchi; S Itagaki; T Mikami; H S Baek; K Doi; J W Yoon
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis.

Authors:  M Carocci; N Cordonnier; H Huet; A Romey; A Relmy; K Gorna; S Blaise-Boisseau; S Zientara; L Bakkali Kassimi
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

Review 4.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

Review 5.  The long-lasting enigma of polycytidine (polyC) tract.

Authors:  Velia Penza; Stephen J Russell; Autumn J Schulze
Journal:  PLoS Pathog       Date:  2021-08-04       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.